Patent details

EP1423124 Title: LYOPHILIZED FORMULATION COMPRISING OLANZAPINE

Basic Information

Publication number:
EP1423124
PCT Application Number:
PCT/US/2002/019799
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP027496348
PCT Publication Number:
WO/2003/007912
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LYOPHILIZED FORMULATION COMPRISING OLANZAPINE
French Title of Invention:
FORMULATION LYOPHILISEE D'OLANZAPINE
German Title of Invention:
LYOPHILISIERTE FORMULIERUNG ENTHALTEND OLANZAPIN
SPC Number:

Dates

Filing date:
05/07/2002
Grant date:
08/08/2007
EP Publication Date:
08/08/2007
PCT Publication Date:
30/01/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/06/2004
EP B1 Publication Date:
08/08/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/07/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/07/2002
 
 

Name:
ELI LILLY AND COMPANY
Address:
Lilly Corporate Center, Indianapolis, Indiana 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
08/08/2007
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
DEKEMPER Kurt, Douglas
Address:
United States (US)

2

Name:
NAIL Steven, L.
Address:
United States (US)

3

Name:
FITES Alan, Lee
Address:
United States (US)

Priority

1

Priority Number:
306829 P
Priority Date:
20/07/2001
Priority Country:
United States (US)

2

Priority Number:
386474 P
Priority Date:
07/06/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/5513;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
25/06/2021
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages